Holen Sie sich die Stockscreener-App
20.31
0.68%
-0.14
Vorhandelsmarkt:
20.50
0.19
+0.94%
Schlusskurs vom Vortag:
$20.45
Offen:
$19.805
24-Stunden-Volumen:
411.54K
Relative Volume:
0.72
Marktkapitalisierung:
$551.51M
Einnahmen:
$157.75M
Nettoeinkommen (Verlust:
$-29.73M
KGV:
-17.51
EPS:
-1.16
Netto-Cashflow:
$-21.00M
1W Leistung:
+3.52%
1M Leistung:
+14.68%
6M Leistung:
+59.04%
1J Leistung:
-4.69%
1-Tages-Spanne:
$19.56
$20.50
1-Wochen-Bereich:
$19.53
$21.66
52-Wochen-Spanne:
$8.04
$25.88
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Firmenname
Arcturus Therapeutics Holdings Inc
Sektor
Branche
Telefon
(858) 900-2660
Adresse
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Vergleichen Sie ARCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARCT
Arcturus Therapeutics Holdings Inc
|
20.31 | 555.31M | 157.75M | -29.73M | -21.00M | -1.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-05-28 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-01-28 | Eingeleitet | BTIG Research | Buy |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-07-24 | Eingeleitet | William Blair | Outperform |
| 2023-05-11 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-11-14 | Fortgesetzt | Wells Fargo | Overweight |
| 2022-11-10 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2022-11-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-11-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-08-10 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2022-07-19 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2022-05-11 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2022-04-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-01-31 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2021-08-12 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2021-08-11 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-10 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2021-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-06-25 | Fortgesetzt | Goldman | Neutral |
| 2021-06-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-02-17 | Herabstufung | B. Riley Securities | Neutral → Sell |
| 2021-01-19 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-01-07 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-29 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-12-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-12-29 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-23 | Herabstufung | ROTH Capital | Buy → Sell |
| 2020-12-08 | Bestätigt | B. Riley Securities | Buy |
| 2020-12-07 | Bestätigt | B. Riley Securities | Buy |
| 2020-10-26 | Eingeleitet | Barclays | Overweight |
| 2020-10-06 | Eingeleitet | Citigroup | Buy |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-30 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-16 | Eingeleitet | Raymond James | Outperform |
| 2020-07-13 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-09 | Herabstufung | WBB Securities | Buy → Hold |
| 2020-02-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-02-07 | Eingeleitet | Guggenheim | Buy |
| 2020-02-06 | Eingeleitet | Guggenheim | Buy |
| 2019-04-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-09-20 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2018-01-22 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Arcturus Therapeutics Holdings Inc Aktie (ARCT) Neueste Nachrichten
Cathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus Stock By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK Sells Roku and Roblox, Buys Arcturus Stock - Investing.com
Arcturus Sues AbbVie, Capstan Alleging Trade Secret Theft - Law360
ARK Investment Expands Stake with Purchase in Arcturus Therapeutics (ARCT) - GuruFocus
Arcturus Therapeutics Shows Progress Amid Transition: Why I Assign A Hold Rating - Seeking Alpha
Arcturus Therapeutics (NASDAQ:ARCT) Trading Up 5.4%Here's What Happened - MarketBeat
We're Not Very Worried About Arcturus Therapeutics Holdings' (NASDAQ:ARCT) Cash Burn Rate - 富途牛牛
Goldman Sachs Group Inc. Buys 42,636 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Published on: 2025-09-20 08:03:53 - khodrobank.com
Arcturus Therapeutics (ARCT) Surges 8.7%: Is This an Indication of Further Gains? - Yahoo Finance
Dynamic Technology Lab Private Ltd Takes $299,000 Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate - MSN
Arcturus Therapeutics Holdings Inc. $ARCT Shares Bought by Jacobs Levy Equity Management Inc. - MarketBeat
Highs Report: Is Arcturus Therapeutics Holdings Inc backed by strong institutional buying2025 Dividend Review & Free Reliable Trade Execution Plans - خودرو بانک
Woodline Partners LP Sells 26,470 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Risk Analysis: What’s the beta of Arcturus Therapeutics Holdings Inc. stockGDP Growth & AI Based Buy/Sell Signal Reports - خودرو بانک
Shorts Report: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesEarnings Beat & Capital Protection Trading Alerts - khodrobank.com
Analyst Calls: Can Arcturus Therapeutics Holdings Inc sustain its profitability2025 Market Sentiment & Technical Pattern Based Signals - خودرو بانک
Decliners Report: Is Arcturus Therapeutics Holdings Inc. vulnerable to short sellersPortfolio Update Summary & Stock Timing and Entry Methods - خودرو بانک
Inflation Data: Can Arcturus Therapeutics Holdings Inc sustain its profitabilityWeekly Trend Summary & AI Enhanced Trading Signals - خودرو بانک
US Stocks Recap: Is Arcturus Therapeutics Holdings Inc. affected by consumer sentimentJuly 2025 Market Mood & Growth Focused Entry Reports - خودرو بانک
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth - Nasdaq
Will Arcturus Therapeutics Holdings Inc. benefit from macro trendsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com
Applying Elliott Wave Theory to Arcturus Therapeutics Holdings Inc.July 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Applying big data sentiment scoring on Arcturus Therapeutics Holdings Inc.2025 Earnings Surprises & Entry Point Strategy Guides - newser.com
Visualizing Arcturus Therapeutics Holdings Inc. stock with heatmaps2025 Year in Review & Stepwise Trade Signal Guides - newser.com
Arcturus Therapeutics Holdings Inc. stock prediction for this weekIndex Update & Free Community Supported Trade Ideas - newser.com
Will Arcturus Therapeutics Holdings Inc. stock recover after recent dropJuly 2025 Market Mood & AI Forecasted Stock Moves - newser.com
What is HC Wainwright's Estimate for ARCT Q3 Earnings? - MarketBeat
Invesco Ltd. Acquires 15,836 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Nuveen LLC Takes $635,000 Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Will Arcturus Therapeutics Holdings Inc. benefit from rate cuts2025 Price Momentum & Capital Efficient Trade Techniques - beatles.ru
Vestal Point Capital LP Acquires New Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat
Real time alert setup for Arcturus Therapeutics Holdings Inc. performanceWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Arcturus Therapeutics Holdings Inc. backed by strong institutional buyingJuly 2025 PreEarnings & Weekly Top Stock Performers List - خودرو بانک
American Century Companies Inc. Increases Stock Position in Arcturus Therapeutics Holdings Inc. $ARCT - Defense World
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Rating of "Buy" by Analysts - MarketBeat
Applying sector rotation models to Arcturus Therapeutics Holdings Inc.Dollar Strength & Low Drawdown Momentum Ideas - Newser
Automated trading signals detected on Arcturus Therapeutics Holdings Inc. - Newser
What’s the beta of Arcturus Therapeutics Holdings Inc. stock2025 Volume Leaders & Weekly Watchlist of Top Performers - خودرو بانک
Is Arcturus Therapeutics Holdings Inc. stock undervalued right nowJuly 2025 Sector Moves & Verified Chart Pattern Trade Signals - خودرو بانک
Does Arcturus Therapeutics Holdings Inc. qualify in momentum factor screeningEarnings Recap Summary & Smart Money Movement Alerts - Newser
Arcturus Therapeutics Holdings Inc. recovery potential after sell offMarket Activity Recap & Precise Entry and Exit Recommendations - Newser
What Fibonacci levels say about Arcturus Therapeutics Holdings Inc. reboundEarnings Overview Report & Reliable Intraday Trade Plans - Newser
Live market analysis of Arcturus Therapeutics Holdings Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Multi factor analysis applied to Arcturus Therapeutics Holdings Inc.Dip Buying & Long-Term Growth Stock Strategies - Newser
Tools to monitor Arcturus Therapeutics Holdings Inc. recovery probabilityMarket Trend Review & High Conviction Buy Zone Picks - Newser
Relative strength of Arcturus Therapeutics Holdings Inc. in sector analysis2025 Support & Resistance & Weekly Momentum Picks - Newser
Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):